CUSIP 004890109COMMON STOCKACRVQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
48 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 8.34M | $20.10M | 0 | Held |
| 2 | Sands Capital Alternatives, LLC | 2.12M | $5.12M | 0 | Held |
| 3 | Citadel Advisors LLC | 1.64M | $3.96M | +100.6K | Added |
| 4 | Wellington Management Group LLP | 888.1K | $2.14M |
| 0 |
| Held |
| 5 | Vanguard Group Inc | 698.9K | $1.68M | +72.7K | Added |
| 6 | Renaissance Technologies LLC | 634.2K | $1.53M | +10.8K | Added |
| 7 | Two Sigma Investments, LP | 585.1K | $1.41M | +265.9K | Added |
| 8 | Marshall Wace, LLP | 496.1K | $1.20M | +346.4K | Added |
| 9 | Acorn Capital Advisors, LLC | 405.2K | $976.6K | 0 | Held |
| 10 | Ubs Group AG | 348.5K | $840.0K | −334.7K | Reduced |
See every fund holding Acrivon Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders